scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.TRACLI.2017.08.002 |
P698 | PubMed publication ID | 28967606 |
P2093 | author name string | F Velge-Roussel | |
F Dehaut | |||
F Halary | |||
V Chabot | |||
A Héraud | |||
L Lamendour | |||
N Deluce-Kakwata-Nkor | |||
Z Ivanovic | |||
P2860 | cites work | Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules | Q22011207 |
BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction | Q24675250 | ||
Dendritic cell biology and regulation of dendritic cell trafficking by chemokines | Q34129744 | ||
Murine Langerin+ dermal dendritic cells prime CD8+ T cells while Langerhans cells induce cross-tolerance | Q34342500 | ||
Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors | Q34555562 | ||
The control of immunity and tolerance by dendritic cell | Q35152256 | ||
Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years | Q35776408 | ||
Characterization of resident and migratory dendritic cells in human lymph nodes | Q35894149 | ||
Functional diversity and plasticity of human dendritic cell subsets | Q36090933 | ||
pDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation | Q36593800 | ||
Tolerogenic and activatory plasmacytoid dendritic cells in autoimmunity | Q36660641 | ||
Dendritic cells: understanding immunogenicity | Q36986703 | ||
Taming cancer by inducing immunity via dendritic cells | Q36990604 | ||
TPL-2 negatively regulates interferon-beta production in macrophages and myeloid dendritic cells | Q37331514 | ||
Langerhans cells are generated by two distinct PU.1-dependent transcriptional networks | Q37397836 | ||
Human tolerogenic DC-10: perspectives for clinical applications. | Q38078109 | ||
Human dendritic cell subsets | Q38101992 | ||
Adoptive transfusion of tolerant dendritic cells prolong the survival of renal allografts: a systematic review | Q38170168 | ||
Harnessing the properties of dendritic cells in the pursuit of immunological tolerance | Q38682156 | ||
Targeting antigens through blood dendritic cell antigen 2 on plasmacytoid dendritic cells promotes immunologic tolerance | Q40417583 | ||
Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells | Q42012476 | ||
Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells | Q43120646 | ||
Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells | Q44986020 | ||
Vitamin D3 Induces Tolerance in Human Dendritic Cells by Activation of Intracellular Metabolic Pathways | Q49160110 | ||
TGF-beta-exposed plasmacytoid dendritic cells participate in Th17 commitment. | Q50631614 | ||
Functional Langerinhigh-Expressing Langerhans-like Cells Can Arise from CD14highCD16- Human Blood Monocytes in Serum-Free Condition. | Q54205001 | ||
Dermal-resident CD14+ cells differentiate into Langerhans cells | Q77149823 | ||
Human blood BDCA-1 dendritic cells differentiate into Langerhans-like cells with thymic stromal lymphopoietin and TGF-β | Q87551598 | ||
Histone deacetylase inhibitor valproic acid affects plasmacytoid dendritic cells phenotype and function | Q87703370 | ||
P921 | main subject | dendritic cell | Q506253 |
P577 | publication date | 2017-09-26 | |
P1433 | published in | Transfusion Clinique et Biologique | Q15758506 |
P1476 | title | Differentiation of human dendritic cell subsets for immune tolerance induction |
Q61812341 | Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy | cites work | P2860 |
Search more.